Evidence map›Paper›PMID 25541737›Full record

ArticlePloS one2014

Increasing fatty acid oxidation remodels the hypothalamic neurometabolome to mitigate stress and inflammation.

Joseph W McFadden, Susan Aja, Qun Li, Veera V R Bandaru, Eun-Kyoung Kim, Norman J Haughey, Francis P Kuhajda, Gabriele V Ronnett

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. TheAging · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Joseph W McFaddenCenter for Metabolism and Obesity Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Susan AjaCenter for Metabolism and Obesity Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Qun LiCenter for Metabolism and Obesity Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Veera V R BandaruDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Eun-Kyoung KimDepartment of Brain Science, Daegu Gyeongbuk Institute of Science and Technology, Daegu, South Korea.
Norman J HaugheyDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Francis P KuhajdaDepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Gabriele V RonnettCenter for Metabolism and Obesity Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Brain Science, Daegu Gyeongbuk Institute of Science and Technology, Daegu, South Korea.
Johns Hopkins Medicine · USJohns Hopkins University · USDaegu Gyeongbuk Institute of Science and Technology · KR

Funding

OLFACTORY ABNORMALITIES IN THE MODELING OF RETT SYNDROMER01NS041079 · NINDS · JOHNS HOPKINS UNIVERSITY · PI RONNETT, GABRIELE V · 2000 to 2013
$3.5M
NINDS NIH HHS R01 NS041079
6 · The paper itself

Abstract

Modification of hypothalamic fatty acid (FA) metabolism can improve energy homeostasis and prevent hyperphagia and excessive weight gain in diet-induced obesity (DIO) from a diet high in saturated fatty acids. We have shown previously that C75, a stimulator of carnitine palmitoyl transferase-1 (CPT-1) and fatty acid oxidation (FAOx), exerts at least some of its hypophagic effects via neuronal mechanisms in the hypothalamus. In the present work, we characterized the effects of C75 and another anorexigenic compound, the glycerol-3-phosphate acyltransferase (GPAT) inhibitor FSG67, on FA metabolism, metabolomics profiles, and metabolic stress responses in cultured hypothalamic neurons and hypothalamic neuronal cell lines during lipid excess with palmitate. Both compounds enhanced palmitate oxidation, increased ATP, and inactivated AMP-activated protein kinase (AMPK) in hypothalamic neurons in vitro. Lipidomics and untargeted metabolomics revealed that enhanced catabolism of FA decreased palmitate availability and prevented the production of fatty acylglycerols, ceramides, and cholesterol esters, lipids that are associated with lipotoxicity-provoked metabolic stress. This improved metabolic signature was accompanied by increased levels of reactive oxygen species (ROS), and yet favorable changes in oxidative stress, overt ER stress, and inflammation. We propose that enhancing FAOx in hypothalamic neurons exposed to excess lipids promotes metabolic remodeling that reduces local inflammatory and cell stress responses. This shift would restore mitochondrial function such that increased FAOx can produce hypothalamic neuronal ATP and lead to decreased food intake and body weight to improve systemic metabolism.

Indexed as

MetabolomeStress, Physiological4-ButyrolactoneAdenosine TriphosphateAMP-Activated Protein KinasesAnimalsAppetite DepressantsCell LineCells, CulturedCeramidesCholesterol EstersCricetinaeGlyceridesGlycerol-3-Phosphate O-AcyltransferaseHumansHypothalamus2-(nonylsulfonamido)benzoic acid4-Butyrolactone4-methylene-2-octyl-5-oxofuran-3-carboxylic acidAdenosine TriphosphateAMP-Activated Protein KinasesAppetite DepressantsCeramidesCholesterol EstersGlyceridesGlycerol-3-Phosphate O-Acyltransferaseortho-AminobenzoatesPalmitatesReactive Oxygen SpeciesSulfonamides

Identifiers

PMID25541737
PMCPMC4277346
OpenAlexW1968782406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.